Introduction
============

The isoquinoline ring system has considerable relevance in drug development, since it is found in both complex \[[@R1]\] and "simple" alkaloids (variously substituted derivatives of the native isoquinoline) isolated from different plants \[[@R2]\], and antiviral and antimicrobial activities have been found for numerous isoquinoline alkaloids \[[@R3]\]. Further, isoquinoline is regarded as a "privileged scaffold" in drug design, and a large number of drug candidates containing this partial structure are in clinical development \[[@R4]\]. Consequently, synthetic approaches enabling a free variation of substituents on this heteroaromatic ring system are required. Numerous methods have been published over the decades for the construction of highly substituted isoquinolines \[[@R4]\]. Alternatively, subsequent functionalization of isoquinolines is feasible, e.g., via Pd-catalyzed C--H functionalization \[[@R5]\] or regioselective direct ring metalation (at C1) \[[@R6]--[@R8]\]. General aspects of the direct methylation of electron-deficient *N*-heterocycles have been reviewed \[[@R9]\].

In a project aimed at the synthesis of tri- and tetracylic alkaloids containing the isoquinoline scaffold, we were interested in isoquinoline building blocks which bear a methyl group at C1, since this group should, due to its intrinsic C--H acidity, open opportunities for further functionalization. Since most isoquinoline alkaloids bear hydroxy and/or methoxy substituents at the positions 6 and 7, we regarded 7-hydroxy-6-methoxy-1-methylisoquinoline (**1**) as well as analogues containing a protected 7-hydroxy group as highly attractive building blocks for our project. A literature search revealed that compound **1** is in fact a natural product. It was isolated from the trunk bark of the Taiwanese tree *Hernandia nymphaeifolia* (Hernandiaceae) in 1996 \[[@R10]\]. No data on the biological activities of this alkaloid have been reported so far. Further, this literature search showed that two total syntheses of isoquinoline **1** had been published even before its identification as a natural product ([Fig. 1](#F1){ref-type="fig"}). In 1963, Franck and Blaschke \[[@R11]\] obtained **1** by dehydrogenation of its 1,2,3,4-tetrahydro analogue (which itself had to be prepared in several steps) with MnO~2~ in poor yield (24% crude product; yield of the final crystallization step for purification not given). In 1965, Bruderer and Brossi \[[@R12]\] reported on an approach whose central step was a Pictet--Gams cyclization of *N*-acetylated β,3-dimethoxy-4-benzyloxyphenethylamine, which gave the 7-*O*-benzyl derivative of alkaloid **1** in 27% yield. The required precursor is available from commercially available precursor **2** via a nitrostyrene intermediate in three steps in 45% overall yield \[[@R13]\]. In conclusion, no efficient approach to this "simple" alkaloid **1** has yet been published.

![Previously published total syntheses of alkaloid **1** \[[@R11]--[@R12]\].](Beilstein_J_Org_Chem-14-130-g002){#F1}

This prompted us to work out a novel synthetic access to alkaloid **1**. Our new strategy was fueled by our previous findings in the course of new approaches to benzylisoquinoline, oxoaporphine \[[@R7]\], and oxoisoaporphine alkaloids \[[@R8]\], where we could demonstrate the power of regioselective direct ring metalations of isoquinolines at C1 with sterically hindered amide bases like TMPMgCl∙LiCl (Knochel--Hauser base) \[[@R6]\]. For our present purpose, an appropriate 1-metalated isoquinoline species was to be converted into the corresponding 1-methyl product. Since the 7-hydroxy group of target alkaloid **1** is not compatible with the metalation reagent, the corresponding benzyl ether **3** was selected as central building block.

Results and Discussion
======================

In our previous work we prepared isoquinoline **3** in a three-step procedure starting from commercially available *O*-benzylisovanillin (**2**) in a modified Pomeranz--Fritsch reaction published by Reimann and Renz \[[@R14]\]. In the present investigations, we even optimized this procedure, ending up with a protocol that does not afford purification of any of the intermediates, and gives isoquinoline **3** in a straightforward operation in 65% isolated yield. For this purpose, the starting aldehyde **2** was subjected to a reductive amination with aminoacetaldehyde dimethyl acetal and NaBH~4~, followed by *N*-tosylation and hydrochloric acid-mediated cyclization under concomitant *N*-detosylation and aromatization. Direct ring metalation of **3** with TMPMgCl∙LiCl was performed as described by us previously \[[@R7]\]. First attempts for a direct methylation at C1 with iodomethane failed completely. Only upon addition of catalytic amounts of CuCN∙2LiCl \[[@R15]\] significant methylation took place. The crude reaction mixture contained almost equimolar amounts of the desired 1-methylisoquinoline **4** and starting material **3**. Due to the very similar polarities of **3** and **4**, chromatographic separation was very tedious, and only 34% of methyl compound **4** was isolated, accompanied by about 30% of starting material **3** and mixed fractions. Debenzylation of **4** by catalytic hydrogenation in methanol solution under palladium catalysis gave the alkaloid **1** in almost quantitative yield ([Scheme 1](#C1){ref-type="fig"}).

![Total synthesis of alkaloid **1** via direct ring metalation and methylation.](Beilstein_J_Org_Chem-14-130-g003){#C1}

So this new metalation/methylation protocol offered a new approach to alkaloid **1** with an overall yield (22% from commercially available precursor **2**) much higher than in the above mentioned previously published methods \[[@R11]--[@R12]\]. However, the unsatisfactory separation of 1-methylisoquinoline intermediate **4** from its unmethylated precursor **3** rendered this protocol unattractive. This is a problem that is common to numerous methylation protocols, including methylation of metalated arenes \[[@R16]\], methylation of arenes bearing directing groups with methylmagnesium bromide \[[@R17]\], and direct methylation using radical reactions \[[@R9],[@R18]--[@R19]\].

Hence, we searched for a more viable method for the introduction of the methyl group. A prerequisite was that the organometallic intermediate should be trapped by an electrophile which could later be transformed into a methyl group, but the trapping product should be easily separable from the starting material **3**. For this purpose we selected Eschenmoser's salt (*N*,*N*-dimethylmethyleniminium iodide) as an electrophile. Trapping of the metalated species was expected to give the *N*,*N*-dimethylaminomethyl derivative **5** in reasonable yield. Later on, hydrogenolytic cleavage of the generated benzylamine-type group at C1 should give the desired 1-methyl moiety. Related reductive cleavage reactions have been published earlier by Möhrle \[[@R20]\] for phenolic Mannich bases in the course of the total synthesis of the naphthalene-derived natural product plumbagin.

In fact, trapping 1-metalated isoquinoline **3** with Eschenmoser's salt gave the aminomethyl derivative **5** in 37% yield. Chromatographic separation from starting material **3** (recovered yield: 32%) was unproblematic.

Surprising results were obtained in our hydrogenolysis experiments with **5**, which were aimed at simultaneous *O*-debenzylation at the 7-position and conversion of the *N*,*N*-dimethylaminomethyl group at C1 into a methyl group. Hydrogenation in presence of palladium as catalyst at 1 bar in the presence or absence of small amounts of sulfuric acid gave the phenolic product **6** in high yield with unchanged *N*,*N*-dimethylaminomethyl group. The same result was obtained at high pressure (40 bar) and upon addition of formic acid for accelerating hydrogenolysis \[[@R21]\]. Obviously, and in contrast to earlier reports on related naphthol Mannich bases \[[@R20]\], the benzylamine moiety of **5** is resistant to hydrogenolysis, whereas the benzyl ether is readily removed. This order of reactivity is known from previous work \[[@R22]\]. Since it is further known that quaternary benzylammonium compounds undergo hydrogenolysis easier than the corresponding tertiary benzylamines \[[@R22]\], we converted amine **5** into methoiodide **7** by treatment with iodomethane. This salt was obtained in pure form in 78% yield by simply collecting the precipitate, and there was no indication of an undesired methylation of the ring nitrogen of the isoquinoline. High-pressure hydrogenolysis of **7** gave only minor amounts (about 7%) of the desired alkaloid **1**, but 1-methyl compound **4** with intact *O*-benzyl residue was isolated in 54% yield. The surprising stability of the *O*-benzyl residue in this experiment might be due to the iodide counterion, which is known to be a poison for palladium catalysts. Cleavage of the highly reactive benzylammonium residue still takes place, but *O*-debenzylation is predominantly suppressed by this catalyst poison. Finally, poisoning of the catalyst was prevented by simply passing a solution of the methoiodide **7** through a chloride-loaded ion exchanger prior to catalytic hydrogenation. In this manner alkaloid **1** was obtained in 94% yield (18% overall yield from commercially available precursor **2**, [Scheme 2](#C2){ref-type="fig"}).

![Total synthesis of alkaloid **1** via the aminomethyl intermediate **5** and selectivity's found in debenzylation experiments.](Beilstein_J_Org_Chem-14-130-g004){#C2}

Conclusion
==========

In conclusion, we have worked out two novel protocols for the introduction of a methyl group at C1 of isoquinolines. These were applied to the total synthesis of the alkaloid 7-hydroxy-6-methoxy-1-methylisoquinoline (**1**), but should also be of value for the synthesis of other 1-methylisoquinolines. We could demonstrate that the aminomethylation of metalated arenes with Eschenmoser's salt followed by hydrogenolytic cleavage is a highly attractive alternative to direct ring methylations. Further, new insights into selectivity of *O*- and *N*-debenzylation reactions should be useful for future natural product and drug syntheses.

Experimental
============

For experimental procedures and copies of ^1^H and ^13^C NMR spectra of all compounds see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}.
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